Health Professionals Perspective on Suicide

March 2, 2023 updated by: Syeda AYAT E ZAINAB Ali

Health Professionals Perspective on Suicide: A Study of Their Attitude, Challenges and Suicide Prevention

The aim is to investigate how health professionals view/respond towards suicidal patients, what was their attitude, experiences and difficulties/challenges they faced while dealing with suicidal patients (whether successful or unsuccessful), and what measures/methods are optimal or could be used to prevent suicide from the perspective of mental and non mental health professionals through concurrent mixed methods study approach.

Study Overview

Study Type

Observational

Enrollment (Anticipated)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Syeda Ayat e Zainab Ali, PhD Scholar
  • Phone Number: +923121319004
  • Email: zai_nab1@hotmail.com

Study Contact Backup

Study Locations

    • Capital
      • Islamabad, Capital, Pakistan, 44000
        • Recruiting
        • International Islamic University, Islamabad Pakistan
        • Contact:
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

25 years to 60 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Considering the study design (concurrent mixed methods), a sample size of sixteen health professionals from different specialties (n=4, Accident and Emergency, n=4 Medicine, n=4 Surgery, n=4 Mental Health) who are the front line clinicians dealing with suicidal behavior will be recruited for the qualitative study. For the quantitative study, the sample will comprised of ninety (n=100) health professionals from respective departments (n=50, (Non Mental Health Professionals, n=50 Mental Health Professionals). Data will be collected through purposive sampling technique.

Description

Inclusion Criteria:

  • Health professionals having at least 1 year of experience in dealing with suicide cases irrespective of the outcome will be included.
  • Qualification of Health professionals should be at least MBBS with permanent PMDCP registration.
  • Health professionals who are willing to participate voluntarily and provide written informed consent will be included.

Exclusion Criteria:

  • Health Professionals with prior and present history of psychiatric consultation will be excluded.
  • Health Professionals without direct experience in handling suicidal patients will be excluded.
  • Nurses and Paramedical staff will be excluded from the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Mental Health Professionals
Non Mental Health Professionals

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Interview Protocol for Qualitative Study
Time Frame: Day 1
A interview protocol for qualitative study will comprised of detailed demographic sheet and open ended questions.
Day 1

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The Understanding Suicidal Patients (USP) scale
Time Frame: Day 1
The Understanding Suicidal Patients (USP) scale (Samuelsson, Asberg, & Gustavsson, 1997) will be used to measure willingness to provide care to suicide attempters and to assess the professional's understanding and sympathy for these patients.
Day 1
The Stigma of Suicide Scale (SOSS-SF)
Time Frame: Day 1
The Stigma of Suicide Scale (SOSS-SF) is a 16-item short form have been developed to examine attitudes towards "a prototypical person who completed suicide"
Day 1
Attitudes towards Suicide Scale
Time Frame: Day 1
The scale is used to examine the respondents' opinions and attitudes towards suicide. Factors measured by the scale are: (1) acceptability of suicide; (2) suicide as a sign of mental illness; (3) the belief that persons who commit suicide will be punished after death; (4) the opinion that suicidal people should communicate their problems; (5) the intention to hide past suicidal behavior; and (6) the opinion that suicide should be discussed and reported openly among friends or in the news.
Day 1
Attitudes towards Suicide Prevention Scale
Time Frame: Day 1
Attitude toward suicide prevention scale is a 14-item, self-rated, 5-point Likert scale (Strongly agree to strongly disagree) will be used to asses attitudes towards suicide prevention.
Day 1
Difficulties in Suicidal Behaviors Intervention Questionnaire - Version for Psychologists and Doctors (DSBQ)
Time Frame: Day 1
To assess the difficulties of health professionals when facing a patient who seeks help after a suicide attempt.
Day 1

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Dr Tamkeen Saleem, PhD, International Islamic University, Islamabad, Pakistan
  • Study Chair: Dr Michelle O'Reilly, PhD, University of Leicester and Leicestershire Partnership NHS Trust
  • Study Chair: Dr Stefan M Schulz, PhD, University of Wuerzburg

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2021

Primary Completion (Anticipated)

March 29, 2023

Study Completion (Anticipated)

April 30, 2023

Study Registration Dates

First Submitted

September 24, 2021

First Submitted That Met QC Criteria

September 24, 2021

First Posted (Actual)

October 5, 2021

Study Record Updates

Last Update Posted (Estimate)

March 3, 2023

Last Update Submitted That Met QC Criteria

March 2, 2023

Last Verified

March 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • LWL-HPPS

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Suicide, Attempted

Subscribe